The etiology of central nervous system (CNS) infections such as meningitis and 25 encephalitis remains unknown in a large proportion of cases partly because the diversity of 26 pathogens that may cause CNS infections greatly outnumber available test methods. Here we 27 present a metagenomic next generation sequencing (mNGS) based approach for broad-range 28 detection of pathogens associated with CNS infections, which is suitable for application in the 29 acute care hospital setting. Using an Illumina MiSeq benchtop sequencer and the IDseq pipeline 30 for identifying pathogens in metagenomic sequence data, we show that the analytical sensitivity 31 of mNGS to detect pathogens is comparable to that of PCR in simulated cerebrospinal fluid 32 (CSF) specimens. We then applied this method for pathogen detection in 74 CSF specimens 33 from patients with suspected CNS infections that were previously tested by culture and/or PCR.
Introduction
bioinformatics expertise for data analysis. We hypothesized that a simplified, low throughput 92 approach adapted for implementation in an acute care diagnostic microbiology laboratory will 93 provide actionable, clinically useful data with faster turnaround time and thus benefit a larger 94 patient population with CNS infections of unknown etiology. 95 To this end, Illumina MiSeq is a low cost, benchtop sequencing platform that is suitable 96 for applications such as small genome sequencing, target gene sequencing and 16S rRNA 97 sequencing. MiSeqDx version of the instrument is also the first FDA-regulated, CE-IVD-98 marked, NGS platform for in vitro diagnostic (IVD) testing. MiSeq system offers simpler NGS 99 library preparation protocol, very low input DNA requirement, high quality data and faster 100 turnaround time. This platform is comparable to the larger Illumina HiSeq 2000 platform in its 101 ability to sequence microbes from host-associated and environmental specimens(24). However, 102 use of the MiSeq platform has not been standardized for metagenomic pathogen detection in 103 clinical samples. In this study, we have determined that the analytical sensitivity of a MiSeq-104 based, shotgun metagenomic sequencing approach to detect bacterial and viral pathogens in 105 cerebrospinal fluid (CSF) is comparable to PCR assays and then optimized a bioinformatic 106 approach for high specificity based on a publicly accessible software platform for metagenomic 107 detection of pathogens (https://idseq.net) (25, 26) . The optimized approach was then applied to a 108 set of retrospectively collected and previously tested CSF specimens (n=74) with an aim to reads, the qPCR C T values for different pathogens were more precisely correlated to their mNGS 138 NT reads (R = 0.96; p<0.0001) (Figures 1 A and1B) . mNGS assay detected all spiked pathogens 139 that were detectable by qPCR. Even a strain of H. influenzae that was spiked at a very low 140 quantity, and thus undetectable by qPCR, was detected by mNGS. Based on these results, a 141 simplified laboratory workflow was set for clinical validation (Figure 2 ). 142 143 Establishment of mNGS bioinformatics workflow 144 While the DNA associated with all spiked pathogens were detected by mNGS using the 145 IDseq software with high sensitivity, the specificity of mNGS results was poor using the default 146 settings. In this setting, sequence reads from specimens mapped to a large number of taxa that 147 include both common contaminants as well as bioinformatic artifacts originating from poor 148 quality alignments making it difficult to differentiate true positive results from false positive 149 results ( Supplementary Figure 1) . Along with the spiked specimens, this is also reflected in the 150 IDseq results of known negative CSF samples as well as in the negative control water sample.
151
Compared to the IDseq results, Metaphlan2 results were relatively more specific but had poor 152 sensitivity. For example, Metaphlan2 failed to detect low concentrations of S. pneumoniae DNA 153 and H. influenzae DNA in all samples. Even adenoviral DNA was undetectable despite being 154 strongly positive by qPCR ( Supplementary Figure 2) . In order to improve the specificity of 155 IDseq results instead, we first applied a background subtraction method. A background dataset 156 was created from 40 negative CSF samples from the clinical validation study. The background 157 dataset was then applied to the training set (n=10) and various filters were applied to adjust the 158 sensitivity and specificity of IDseq results based on previous knowledge of spiked organisms and 159 qPCR results. The optimal filter set that cleared all false positive results from the water sample 160 and negative CSF samples were: i) NT reads  10; ii) NT Z score  8; iii) aligned base pair 161 length  50 bp; and iv) Non redundant (NR) reads  2. While this approach significantly 162 improved the specificity of mNGS ( Supplementary Figure 3) , true positive results for E. coli 163 were filtered out because E. coli was also a common contaminant in mNGS. Therefore, we 164 established a manual review process for E. coli results. We noted that contaminating E. coli 165 DNA in our specimens mapped to E. coli strain BL21 or E. coli blaTEM1 gene and therefore 166 these results can be ignored. Figure 4 ) and the 173 number of sequence reads in this specimen aligned to E. coli CFT073 genome was much lower 174 than BL21 (6 aligned reads versus 58 reads). We noted that unlike bacteria and eukaryotes, low 175 count true viral reads were filtered out when the same filter set was applied. Therefore, to 176 identify viral DNA in the test set data, we decided to apply a simple filter of only "NR reads  2" 177 after background subtraction. All options for applying the background and customized filters are were 14% and 27%, respectively. Specimens considered to be "bloody taps" (RBC/WBC >500) 199 were excluded. By Gram staining, about 23% and 18% specimens had very high (4+) WBC and 200 RBC scores, respectively. By culture, 11 samples (15%) were positive and when combined with 201 the PCR results 28 (39%) samples were positive for a bacterial, viral or fungal pathogen. A total 202 of 9 samples were positive for enterovirus, which is an RNA virus. Because RNA viruses are not 203 expected to be detected by the DNA-specific protocol described in this study, these samples were The DNA concentration in CSF specimens ranged from 0.14 to 19.9 ng/l with an 206 average of 1.3 ng/l ( Supplementary Table 1 ). Because the Illumina Nextera XT protocol 207 requires 1 ng DNA in 5 l volume, 11 specimens had lower DNA concentration than the 208 minimally required concentration. For these specimens, 5 l of the undiluted DNA extracts were 209 used for library preparation irrespective of their concentration. Other specimen extracts were 210 diluted to 1 ng DNA as the starting material for library preparation. The NGS library 211 concentration based on Kappa qPCR ranged from 0.4 to 150 nM with an average of 19.9 nM.
212
The Illumina MiSeq protocol requires at least 2 nM DNA but 12 specimens had lower than the 213 minimum library concentration. For these specimens, 5 l of the undiluted libraries were (25,201,237 and 20,188,913, respectively) were not significantly different from the overall 221 average sequence read outputs. Non-host reads ranged from 574 -2,430,956 reads with an 222 average of 56,179 reads, accounting for an average of 0.3% of total reads. The average run time 223 for data analysis was 1.22 h. Data analysis for 90% and 74% of specimens were completed in <2 224 and <1 h, respectively.
225
By mNGS, performed according to the standard operating procedures described in Figure   226 2, a total of 19 samples were deemed positive for the presence of a pathogen (Figure 3 ).
227
Compared to the conventional tests, mNGS missed one positive result (CW005), which was 228 Staphylococcus epidermidis that had grown in enrichment broth only, and was originally 229 reported as a potential contaminant. On the other hand, mNGS identified 4 additional pathogens 230 that were not detected by conventional methods. S. agalactae was detected in two specimens 231 from patients aged 0.09 and 0.03 years, respectively. The organisms were not recovered by Figure 5) . It was noted that E. coli DNA in 244 69 out of 74 specimens were related to BL21 strains. The remaining 3 specimens were related to 245 E. coli reference strain C9. However, all of these specimens were strongly positive for N. 246 meningitidis and were therefore ignored. Among the viral taxa identified, Chimpanzee 247 anellovirus and Torque Teno mini virus were deemed insignificant by the clinical microbiologist.
248
Overall, the sensitivity, specificity and accuracy of mNGS results on 74 CSF specimens 249 with the customized bioinformatic approach in IDseq were all 95% (Table 3) . For comparison, 250 all the mNGS data were also analyzed by the Metaphlan2 pipeline and the results were reviewed 251 by a clinical microbiologist. All E. coli positive results, common environmental contaminants 252 such as Ralstonia picketii and clinically non-relevant taxa were interpreted as negative results.
253
The sensitivity, specificity and accuracy of mNGS results using Metaphlan2 were 58%, 96% and 254 86% respectively. The potential for the application of NGS based, clinical metagenomics approach for the 258 diagnosis of infectious diseases has been recognized for a few years now (8, 9, 15) . Currently, 259 initiatives are being taken to standardize the approach for routine application in the clinical 260 microbiology laboratories (20, 22, 23) . Because of the high cost and substantial expertise and 261 labor involved, mNGS approach appears suitable only for specific applications in clinical 262 microbiology such as for detection of pathogens in CSF for the diagnosis of meningitis and 263 encephalitis because these infections are potentially life threatening and also because of the fact 264 that a wide range of pathogens can cause such infections that are not routinely detected by 265 standard methods. The present study was performed to establish and validate an mNGS approach 266 for pathogen detection in CSF for the diagnosis of CNS infections that can be implemented in 267 acute care hospital laboratories. The protocol has been developed for a low throughput setting so 268 that single specimens can be processed without waiting for additional specimens for batching.
269
Laboratory workflow and the data analysis workflow have been designed to be relatively simpler 270 and faster compared to previously reported approaches. The procedure does not require huge data and sequence reads so that low level pathogen DNA can be detected. Our analytical 280 sensitivity data shows that the MiSeq-based approach was able to detect low level pathogen 281 DNA with qPCR C T 35 or higher. Even spiked H. influenzae that was undetectable by qPCR was 282 detected by mNGS. Given the fact that PCR is widely considered to be one of the most sensitive 283 method for pathogen detection, an equivalent or superior sensitivity to qPCR indicates that 284 mNGS approach can be applied for the diagnosis of infectious diseases. In the clinical validation, 285 we noted that despite minimal quality control and high variability in extracted DNA 286 concentration, NGS library concentration, sequence read output, host versus non-host reads and 287 IC reads, the mNGS approach was capable of identifying all pathogens but one that were 288 identified by conventional methods. The only pathogen that was missed was a known skin 289 contaminant that grew in enrichment broth only and was confirmed to be negative in this study.
290
On the other hand, the fact that mNGS was able to identify S. agalactiae in two specimens that 291 did not grow in culture suggests that mNGS approach is a powerful method for identification of 292 fastidious pathogens or those that have failed to grow in culture because of prior antibiotic 293 treatment.
294
Because NGS generates massive amounts of sequence data, interpretation of this data for 295 clinical use is challenging. In order to develop a practical bioinformatics approach, with high 296 sensitivity and specificity for pathogen detection in CSF, we tested various existing 297 bioinformatics tools including Metaphlan2 (27) and IDseq(28) using our training set. Metaphlan2 298 performs taxonomic assignment of metagenomic shotgun sequencing data at the species level 299 using a unique database of clade specific marker genes as the reference database(27).
300
Metaphlan2 is performed in command line, Linux or MacOS environments and therefore 301 requires some bioinformatics expertise and experience working in a command line environment.
302
IDseq is an online platform for metagenomic sequence analysis, where the user uploads raw 303 sequence data to the platform and the rest of the procedure, including adapter trimming, data 304 quality control, host DNA subtraction and alignment to both NCBI nucleotide (NT) database and 305 non-redundant (NR) database is performed automatically.
306
When Metaphan2 was applied to our training and validation dataset, the specificity was 307 high but the sensitivity was poor. For example, in the validation dataset, Metaphlan2 missed 8 of 308 the 19 positive results by standard methods. On the other hand, when IDSeq pipeline was applied 309 to our training data set, all spiked pathogens were detected with high sensitivity but the 310 metagenomic sequence analysis returned a long list of bacterial, viral and eukaryotic taxa making 311 it very difficult to differentiate true positive results from background taxa and/or potential 312 contaminants, particularly when the target pathogen was present at low quantities 313 ( Supplementary Figure 1) . The IDseq platform, however, offered us with a wide range of options 314 to utilize additional statistical analyses and data filters to improve the sensitivity and specificity 315 of the methods and allow for easier interpretation of data. First, we created a background dataset 316 using data from 40 known negative samples. After background subtraction, while IDseq ranks 317 taxa based on an aggregate score calculated from NT/NR 'z scores' and 'reads per million' 318 (rpm), this method alone was not sufficient to delineate specific results from the list of potential 319 pathogens and non-specific taxa. We therefore applied additional filters and manual review 320 process as described in the results section in order to improve the interpretability of results.
321
Interestingly, when this approach was applied to the validation data set, the returned results were 322 highly accurate, sensitive and specific (95%) compared to the standard methods.
323
A limitation of our current approach is that we did not incorporate methods for detecting 324 RNA viruses. A combined method for detection of both DNA and RNA targets by mNGS would 325 expand the target pathogen range of the assay but would increase the cost of testing and increase 326 the complexity of the procedure. Most pathogens detected by mNGS in our study were relatively 327 common bacterial and viral pathogens, reflecting the nature of our pediatric population, but the 328 high sensitivity and specificity of our approach suggests the potential for detecting more unusual 329 pathogens in a higher risk population. We are currently undertaking a study to investigate the 330 clinical impact of implementing mNGS for prospective pathogen detection in selected CSF 331 specimens in a pediatric population.
332
In conclusion, we have developed a clinical metagenomic diagnostic approach for CNS 333 infections which has demonstrated superior accuracy, sensitivity and specificity, compared to 334 previously reported methods. The method offers faster turnaround time, minimal hands on time 335 and can be easily implemented in an acute care diagnostic microbiology laboratory, with a 336 moderate level of molecular expertise, and with modest capital investment. The cost of NGS is 337 still much higher than standard microbiological methods. Therefore, application of this approach 338 for routine CSF testing may not be economically viable at this time. Instead, the approach should 339 be applied to selected patient specimens that are negative for a potential CNS pathogen by servers. The cost of sequencing is reduced through sample batching, but this, along with time 345 required for sample shipping, increases the turnaround time, which can be detrimental for 346 managing CNS infections. Therefore, the method described here, designed for use in a hospital 347 acute care setting, should be of immediate benefit to patients with undiagnosed CNS infections. Table 1 , and vortexed for 10 sec before extraction of DNA. Four CSF specimens were left 380 unspiked to serve as negative control. 85% (95% CI: 57%-100%) 86% (95% CI: 67%-95%) Negative predictive value (NPV) 87% (95% CI: 80%-92%) 98% (95% CI: 89%-100%) Accuracy 86% (95% CI: 77%-93%) 95% (95% CI: 87%-99%) 585 CW004  CW005  CW006  CW007  CW008  CW010  CW012  CW013  CW015  CW016  CW018  CW019  CW020  CW021  CW022  CW023  CW024  CW025  CW028  CW029  CW030  CW031  CW033  CW034  CW036  CW037  CW038  CW040  CW043  CW044  CW045  CW046  CW048  CW049  CW050  CW052  CW053  CW054  CW055  CW056  CW057  CW058  CW060  CW063  CW064  CW066  CW068  CW070  CW071  CW072  CW074  CW075  CW077  CW078  CW081  CW082  CW084  CW086  CW087  CW088  CW090  CW093  CW094  CW095  CW098  CW099  CW100  CW101  CW102  CW103  CW322 
